Related Experiment Video
Updated: Jul 31, 2025

07:11
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
Published on: December 8, 2023
1.6K
Protocol for vision transformer-based evaluation of drug potency using images processed by an optimized Sobel
Yongheng Wang1, Weidi Zhang2, Yi Wu2
1Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA.
STAR Protocols
|May 3, 2023
Summary
This study introduces a novel, high-throughput method for assessing anticancer drug efficacy using deep learning, significantly reducing time and cost compared to traditional assays.
Area of Science:
- Biotechnology
- Computational Biology
- Drug Discovery
Background:
- Traditional anticancer drug screening is often time-consuming, labor-intensive, and expensive.
- There is a need for more efficient and cost-effective methods to evaluate drug efficacy.
Purpose of the Study:
- To present a novel protocol for label-free, high-throughput drug efficacy assessment.
- To utilize deep learning, specifically a vision transformer and Conv2D, for predicting drug potency.
Main Methods:
- The protocol involves cell culture, drug treatment, and data collection.
- Deep learning models were developed using vision transformer and Conv2D architectures.
- Data preprocessing steps were detailed for model training.
Main Results:
- The developed deep learning models can predict drug potency with high throughput.
- The label-free approach eliminates the need for costly chemical reactions.
- The protocol is adaptable for screening chemicals impacting cell density or morphology.
Conclusions:
- This novel protocol offers a faster, cheaper, and more efficient alternative for anticancer drug screening.
- The methodology can be extended to screen various chemical compounds affecting cellular characteristics.
- The integration of deep learning with cell imaging accelerates the drug discovery pipeline.

